Suppr超能文献

医生推荐低能量全饮食替代方案作为肥胖常规治疗是否具有成本效益?

Is Doctor Referral to a Low-Energy Total Diet Replacement Program Cost-Effective for the Routine Treatment of Obesity?

机构信息

Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

Obesity (Silver Spring). 2019 Mar;27(3):391-398. doi: 10.1002/oby.22407.

Abstract

OBJECTIVE

The study objective was to estimate the cost-effectiveness of a commercially provided low-energy total diet replacement (TDR) program compared with nurse-led behavioral support.

METHODS

A multistate life table model and the weight reduction observed in a randomized controlled trial were used to evaluate the quality-adjusted life-years and direct health care costs (in United Kingdom 2017 prices) over a lifetime with TDR versus nurse-led support in adults who had obesity, assuming that (i) weight returns to baseline over 5 years and (ii) a 1-kg weight loss is maintained after 5 years following TDR.

RESULTS

The per-person costs of the TDR and nurse-led programs were £796 and £34, respectively. The incremental cost-effectiveness ratio of TDR was £12,955 (95% CI: £8,082-£17,827) assuming that all weight lost is regained and £3,203 (£2,580-£3,825) assuming that a 1-kg weight loss is maintained after 5 years. TDR was estimated to be more cost-effective (i.e., lower incremental cost-effectiveness ratios) in older adults and those with a higher BMI, with little difference by gender.

CONCLUSIONS

At current retail prices and with plausible long-term weight regain trajectories, TDR is projected to be cost-effective in adults with obesity and could be considered as an option to treat obesity in routine health care settings.

摘要

目的

本研究旨在评估一种商业提供的低能量全膳食替代(TDR)方案与护士主导的行为支持相比的成本效益。

方法

采用多状态生命表模型和一项随机对照试验中观察到的体重减轻数据,评估在肥胖成年人中使用 TDR 与护士主导支持相比,在一生中的质量调整生命年和直接医疗保健成本(按 2017 年英国价格计算),假设(i)体重在 5 年内恢复到基线水平,以及(ii)在 TDR 后 5 年内维持 1 公斤的体重减轻。

结果

TDR 和护士主导方案的人均成本分别为 796 英镑和 34 英镑。假设所有减轻的体重都恢复,TDR 的增量成本效益比为 12955 英镑(95%CI:8082-17827 英镑);假设在 TDR 后 5 年内维持 1 公斤的体重减轻,增量成本效益比为 3203 英镑(2580-3825 英镑)。TDR 在老年人和 BMI 较高的人群中被估计为更具成本效益(即,较低的增量成本效益比),而性别差异较小。

结论

在当前零售价格下,并且根据合理的长期体重恢复轨迹,TDR 预计在肥胖成年人中具有成本效益,并且可以考虑作为常规医疗保健环境中治疗肥胖的一种选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验